176
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Plasma protein adsorption on Fe3O4-PEG nanoparticles activates the complement system and induces an inflammatory response

, , , , , , & show all
Pages 2055-2067 | Published online: 25 Mar 2019

References

  • SharmaVKAlipourASoran-ErdemZAykutZGDemirHVHighly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)–T(2) MRI contrast agentsNanoscale2015723105191052626010145
  • KossatzSGrandkeJCouleaudPEfficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug deliveryBreast Cancer Res201517111725567532
  • ShiDSadatMEDunnAWMastDBPhoto-fluorescent and magnetic properties of iron oxide nanoparticles for biomedical applicationsNanoscale20157188209823225899408
  • AnselmoACMitragotriSA review of clinical translation of inorganic nanoparticlesAAPS J20151751041105425956384
  • WangYXJSuperparamagnetic iron oxide based MRI contrast agents: current status of clinical applicationQuant Imaging Med Surg201111354023256052
  • MonopoliMPWalczykDCampbellAPhysical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticlesJ Am Chem Soc201113382525253421288025
  • KimJASalvatiAÅbergCDawsonKASuppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafetyNanoscale2014623141801418425340311
  • WalkeyCDChanWCWUnderstanding and controlling the interaction of nanomaterials with proteins in a physiological environmentChem Soc Rev20124172780279922086677
  • HarmsCDatwylerALWiekhorstFCertain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to strokeJ Cereb Blood Flow Metab2013335e1e9
  • InturiSWangGChenFModulatory role of surface coating of superparamagnetic iron oxide Nanoworms in complement opsonization and leukocyte uptakeACS Nano2015911107581076826488074
  • RicklinDHajishengallisGYangKLambrisJDComplement: a key system for immune surveillance and homeostasisNat Immunol201011978579720720586
  • MoghimiSMAndersenAJAhmadvandDWibroePPAndresenTLHunterACMaterial properties in complement activationAdv Drug Deliv Rev201163121000100721689701
  • SzebeniJComplement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicalsMol Immunol201461216317325124145
  • SzebeniJBaranyiLSavaySRole of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studiesJ Liposome Res2002121–216517212604051
  • Salvador-MoralesCFlahautESimESloanJGreenMLHSimRBComplement activation and protein adsorption by carbon nanotubesMol Immunol200643319320116199256
  • Allard-VannierECohen-JonathanSGautierJPEGylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivoEur J Pharm Biopharm201281349850522510695
  • Chanan-KhanASzebeniJSavaySComplement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactionsAnn Oncol20031491430143712954584
  • Santoyo SalazarJPerezLde AbrilOMagnetic iron oxide nanoparticles in 10−40 nm range: composition in terms of magnetite/maghemite ratio and effect on the magnetic propertiesChem Mater201123613791386
  • MahmoudiMAbdelmonemAMBehzadiSTemperature: the “ignored” factor at the NanoBio interfaceACS Nano2013786555656223808533
  • MonopoliMPPitekASLynchIDawsonKAFormation and Characterization of the Nanoparticle–Protein Corona BT – Nanomaterial Interfaces in Biology: Methods and ProtocolsBergesePHamad-SchifferliKTotowa, NJHumana Press2013137155
  • LaemmliUKCleavage of structural proteins during the assembly of the head of bacteriophage T4Nature197022752596806855432063
  • Solorio-RodríguezAEscamilla-RiveraVUribe-RamírezMA comparison of the human and mouse protein corona profiles of functionalized SiO2 nanocarriersNanoscale2017936136511366028875999
  • ShevchenkoATomasHHavlisJOlsenJVMannMIn-gel digestion for mass spectrometric characterization of proteins and proteomesNat Protoc20071628562860
  • ShevchenkoAWilmMVormOMannMMass spectrometric sequencing of proteins silver-stained polyacrylamide gelsAnal Chem19966858508588779443
  • KessnerDChambersMBurkeRAgusDMallickPProteoWizard: open source software for rapid proteomics tools developmentBioinformatics200824212534253618606607
  • EngJKJahanTAHoopmannMRComet: an open-source MS/MS sequence database search toolProteomics2013131222423148064
  • EliasJEGygiSPTarget-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometryNat Methods20074320721417327847
  • KellerANesvizhskiiAIKolkerEAebersoldREmpirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database searchAnal Chem200274205383539212403597
  • NesvizhskiiAIKellerAKolkerEAebersoldRA statistical model for identifying proteins by tandem mass spectrometryAnal Chem200375174646465814632076
  • WinklerRAn evolving computational platform for biological mass spectrometry: workflows, statistics and data mining with MASSyPup64PeerJ2015311e140126618079
  • VizcaínoJADeutschEWWangRProteomeXchange provides globally coordinated proteomics data submission and disseminationNat Biotechnol201432322322624727771
  • VizcaínoJACsordasAdel-ToroN2016 update of the pride database and its related toolsNucleic Acids Res201644D1D447D45626527722
  • BindeaGMlecnikBHacklHClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksBioinforma200925810911093
  • LeinerTHoKYJAMHoVBMulticenter phase-II trial of safety and efficacy of NC100150 for steady-state contrast-enhanced peripheral magnetic resonance angiographyEur Radiol20031371620162712835977
  • WeinsteinJSVarallyayCGDosaESuperparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a reviewJ Cereb Blood Flow Metab2010301153519756021
  • van der KolkLEGrillo-LópezAJBaarsJWHackCEvan OersMHComplement activation plays a key role in the side-effects of rituximab treatmentBr J Haematol2001115480781111843813
  • LozanoOLaloyJAlpanLEffects of sic nanoparticles orally administered in a rat model: biodistribution, toxicity and elemental composition changes in feces and organsToxicol Appl Pharmacol2012264223224522981607
  • LozanoOMejiaJMasereelBToussaintOLisonDLucasSDevelopment of a PixE analysis method for the determination of the biopersistence of sic and tic nanoparticles in rat lungsNanotoxicology20126326327121504370
  • HamadIHunterACSzebeniJMoghimiSMPolyMSMPoly (ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent processMol Immunol200846222523218849076
  • YangALiuWLiZJiangLXuHYangXInfluence of polyethyleneglycol modification on phagocytic uptake of polymeric nanoparticles mediated by immunoglobulin G and complement activationJ Nanosci Nanotechnol201010162262820352902
  • GarayRPEl-GewelyRArmstrongJKGarrattyGRichettePAntibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agentsExpert Opin Drug Deliv20129111319132322931049
  • MoghimiSMAndersenAJHashemiSHComplement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges aheadJ Control Release2010146217518120388529
  • SzebeniJMuggiaFMAlvingCRComplement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro studyJ Natl Cancer Inst19989043003069486816
  • HuZZhangHZhangYWuRen’anZouHNanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticlesColloids Surf B Biointerfaces201412135436124974013
  • SakulkhuUMahmoudiMMauriziLSalaklangJHofmannHProtein corona composition of superparamagnetic iron oxide nanoparticles with various physicochemical properties and coatingsSci Rep2015415020
  • SakulkhuUMahmoudiMMauriziLSignificance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein coronaBiomater Sci20153226527826218117
  • SimbergDZhangW-MMerkulovSContact activation of kallikreinkinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivoJ Control Release2009140330130519508879
  • NemmarAAl-SalamSBeegamSYuvarajuPAliBHThe acute pulmonary and thrombotic effects of cerium oxide nanoparticles after intratracheal instillation in miceInt J Nanomedicine2017122913292228435267
  • MüllerJProzellerDGhazaryanABeyond the protein corona – lipids matter for biological response of nanocarriersActa Biomater20187142043129524674
  • JayaramDTRunaSKempMLPayneCKNanoparticle-induced oxidation of corona proteins initiates an oxidative stress response in cellsNanoscale20179227595760128537609
  • DengZJLiangMMonteiroMTothIMinchinRFNanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammationNat Nanotechnol201161394421170037
  • WangLCuiCLiRStudy on the oxidation of fibrinogen using Fe3O4 magnetic nanoparticles and its influence to the formation of fibrinJ Inorg Biochem2018189586830243119
  • MatsushitaMEndoYFujitaTCutting edge: complement-activating complex of ficolin and mannose-binding lectin-associated serine proteaseJ Immunol200016452281228410679061
  • PetersenSVThielSJenseniusJCThe mannan-binding lectin pathway of complement activation: biology and disease associationMol Immunol2001382–313314911532276
  • KilpatrickDCChalmersJDHuman L-ficolin (ficolin-2) and its clinical significanceJ Biomed Biotechnol201220123311021836813
  • OhtaniKSuzukiYWakamiyaNBiological functions of the novel collectins CL-L1, CL-K1, and CL-P1J Biomed Biotechnol2012201231821836813
  • FujitaTEvolution of the lectin-complement pathway and its role in innate immunityNat Rev Immunol20022534635312033740
  • HamadIAl-HanbaliOHunterACDistinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineeringACS Nano20104116629663821028845
  • HamadIChristy HunterARuttKJLiuZDaiHMoein MoghimiSComplement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnoverMol Immunol200845143797380318602161
  • BandaNKMehtaGChaoYMechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serumPart Fibre Toxicol201411111024382024
  • LiuFTYangRYHsuDKGalectins in acute and chronic inflammationAnn N Y Acad Sci201212531809122329844
  • HadjidemetriouMKostarelosKNanomedicine: evolution of the nanoparticle coronaNat Nanotechnol201712428829028383044
  • HolersVMKinoshitaTMolinaHThe evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of functionImmunol Today19921362312361378280
  • PouwRBVredevoogdDWKuijpersTWWoutersDOf mice and men: the factor H protein family and complement regulationMol Immunol2015671122025824240
  • XueWLiuYZhangNEffects of core size and PEG coating layer of iron oxide nanoparticles on the distribution and metabolism in miceInt J Nanomedicine2018135719573130310275
  • HuangJBuLXieJEffects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticlesACS Nano20104127151716021043459
  • Wolf-GrosseSRokstadAMAliSIron oxide nanoparticles induce cytokine secretion in a complement-dependent manner in a human whole blood modelInt J Nanomedicine2017123927394028579778
  • BosmannMWardPARole of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsisAdv Exp Med Biol201294614715921948367
  • Escamilla-RiveraVUribe-RamírezMGonzález-PozosSLozanoOLucasSDe Vizcaya-RuizAProtein corona acts as a protective shield against Fe3O4-PEG inflammation and ROS-induced toxicity in human macrophagesToxicol Lett2016240117218426518974